Johnson & Johnson (JNJ) Highlights Sustained Efficacy in Vivacity-MG3 Trial [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
TheFly reported on April 22 that JNJ released updated findings from its Phase 3 Vivacity-MG3 trial and ongoing extension study evaluating IMAAVY (nipocalimab-aahu) in adults with generalized myasthenia gravis. The results showed continued symptom improvement, stable disease management, and a consistent safety profile over an extended follow-up period. The data, presented at the American Academy of Neurology 2026 Meeting, also highlighted reduced steroid use and meaningful functional outcomes. Additional analyses examined minimal symptom expression as a treatment goal. The company also confirmed that a head-to-head FcRn study is currently enrolling participants. Johnson & Johnson (JNJ) Highlights Sustained Efficacy in Vivacity-MG3 Trial At the same time, Johnson & Johnson (NYSE:JNJ) reported a regulatory achievement within its MedTech unit. On April 22, 2026, the company secured European CE Mark clearance for the ETHICON 4000 Stapler, a next-generation surgical device built to e
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Half of Americans Think $1,000 Is Needed to Start Investing, They're Wrong [Yahoo! Finance]Yahoo! Finance
- Halozyme appoints Darren Snellgrove as CFO [Seeking Alpha]Seeking Alpha
- Johnson & Johnson Appoints Ryan Koors as Vice President, Investor RelationsBusiness Wire
- 3 Unstoppable Growth Stocks For Years Of Passive Income [Yahoo! Finance]Yahoo! Finance
- AmChamSG Announces 2026-7 Chair and Board of Governors [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/28/26 - Form 8-K
- 4/27/26 - Form 4
- 4/27/26 - Form 4
- JNJ's page on the SEC website